Category: Commentary

These are shorter papers containing commentaries on any topic area within the scope of the journal. They do not necessarily need to be based on original research or reviews of the literature and can be based on opinion, providing the points made are transparent and well-argued.

INDUSTRY AND GOVERNMENT LEADERS OUTLINE POTENTIAL FOR SOCIAL MEDIA TO ACCELERATE PRO DEVELOPMENT

Raritan, NJ, USA – A collaboration designed to open dialogue between industry and government leaders has found “great potential” for social media to support content validity of patient-reported outcomes (PRO) instruments, and outlined how the use of social media can

Posted in Commentary, Value in Health Tagged with: , , , , , ,

“MORE DOCTORS” … FROM ABROAD: A SOLUTION FOR PHYSICIAN MALDISTRIBUTION?

Porto Alegre, Brazil – Social problems, including health care concerns, led millions of people to protest on the streets of Brazil in 2014. Brazil has approximately 18 doctors per 10,000 inhabitants, a number that is above the world’s average of

Posted in Commentary, Value in Health Regional Issues Tagged with: ,

Subgrouping Practice in Early Benefit Assessment in Germany Risks Misusing Evidence-based Medicine

Hannover, Germany – Since 2011, the German AMNOG (Act on the Reform of the Market for Medicinal Products) legislation regulates drug reimbursement in an attempt to reduce national health care costs. The Federal Joint Committee (G-BA) and the Institute for Quality

Posted in Commentary, Value in Health Tagged with: , , , , ,

Nice’s Scientific Credibility Compromised By Recent Amendment To Appraisal Methods

Toronto, ON, Canada – The National Institute for Health and Care Excellence (NICE) is highly regarded for the rigorous methods it adopts for the economic appraisal of health care technologies. A recent amendment to these appraisal methods, however, raises a number

Posted in Commentary, Value in Health Tagged with: , , , ,